
ERFSF
Healthcare · Diagnostics & Research · $16.55B market cap
$96.78-1.26 (-1.3%)Nov 13, 9:30 AM EST
Next report
After the close
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Jan 28, 2027 · upcoming | After the close | — | — | — |
| Apr 27, 2021 | After the close | 0.00 | 1.18 | — |
| Feb 28, 2021 | After the close | 0.00 | 1.17 | — |
| Oct 21, 2020 | After the close | 0.00 | 1.30 | — |
| Aug 5, 2020 | After the close | 0.00 | 1.25 | — |
| May 15, 2020 | After the close | 0.00 | 0.23 | — |
| Mar 3, 2020 | After the close | 0.00 | 0.23 | — |
| Oct 27, 2019 | After the close | 0.00 | 0.33 | — |
| Aug 28, 2019 | After the close | 0.00 | 0.32 | — |
| Apr 25, 2019 | After the close | 0.00 | 0.11 | — |
| Mar 4, 2019 | After the close | 0.00 | 0.10 | — |
| Oct 22, 2018 | After the close | 0.00 | 0.35 | — |
| Jul 30, 2018 | After the close | 0.00 | 0.35 | — |
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection, QA-QC programme,…
| Time not confirmed |
| 0.00 |
| 0.23 |
| — |
| Mar 5, 2018 | After the close | 0.00 | 0.22 | — |